Jackson Square Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Sell |
|
|||||
|
2025
Q1 | $3.92M | Sell |
|
|||||
|
2024
Q4 | $9.35M | Sell |
|
|||||
|
2024
Q3 | $10.7M | Sell |
|
|||||
|
2024
Q2 | $12.2M | Buy |
|
|||||
|
2024
Q1 | $26.9M | Sell |
|
|||||
|
2023
Q4 | $95.2M | Buy |
|
|||||
|
2023
Q3 | $57.9M | Sell |
|
|||||
|
2023
Q2 | $113M | Sell |
|
|||||
|
2023
Q1 | $140M | Sell |
|
|||||
|
2022
Q4 | $123M | Sell |
|
|||||
|
2022
Q3 | $118M | Sell |
|
|||||
|
2022
Q2 | $101M | Buy |
|
|||||
|
2022
Q1 | $205M | Buy |
|
|||||
|
2021
Q4 | $297M | Sell |
|
|||||
|
2021
Q3 | $371M | Sell |
|
|||||
|
2021
Q2 | $519M | Buy |
|
|||||
|
2021
Q1 | $430M | Sell |
|
|||||
|
2020
Q4 | $350M | Buy |
|